These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
603 related items for PubMed ID: 35123604
1. [Association of Next Generation Sequencing Based Genotypic Profiling with MICM Characteristics in NPM1 Mutated Acute Myeloid Leukemia]. Wang B, Ling Y, Dai L, Gu WY, Zhang XW, Xing SS, Li HQ. Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Feb; 30(1):56-60. PubMed ID: 35123604 [Abstract] [Full Text] [Related]
2. The correlation of next-generation sequencing-based genotypic profiles with clinicopathologic characteristics in NPM1-mutated acute myeloid leukemia. Wang B, Yang B, Wu W, Liu X, Li H. BMC Cancer; 2021 Jul 08; 21(1):788. PubMed ID: 34238278 [Abstract] [Full Text] [Related]
3. [The Mutated Gene Sequenced by NGS and the Correlation of Their Coexistent Mutual Exclusiveness in NPM1 Mutated Acute Myeloid Leukemia]. Dai L, Wang ZL, Qiu GQ, Wu YC, Zhang XW, Xing SS, Wang B. Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Dec 08; 29(6):1733-1740. PubMed ID: 34893102 [Abstract] [Full Text] [Related]
5. Influence of genetic co-mutation on chemotherapeutic outcome in NPM1-mutated and FLT3-ITD wild-type AML patients. Wu Q, Zhang Y, Yuan B, Huang Y, Jiang L, Liu F, Yan P, Cheng J, Long Z, Jiang X. Cancer Med; 2024 Aug 08; 13(15):e70102. PubMed ID: 39126219 [Abstract] [Full Text] [Related]
6. CD34 negative HLA-DR negative acute myeloid leukaemia: A higher association with NPM1 and FLT3-ITD mutations. Gajendra S, Gupta R, Thakral D, Gupta SK, Jain G, Bakhshi S, Sharma A, Sahoo RK, Kumar L, Rai S, Singh S, Upadhyay AD. Int J Lab Hematol; 2023 Apr 08; 45(2):221-228. PubMed ID: 36504282 [Abstract] [Full Text] [Related]
8. DNMT3A (R882) mutation features and prognostic effect in acute myeloid leukemia in Coexistent with NPM1 and FLT3 mutations. Kumar D, Mehta A, Panigrahi MK, Nath S, Saikia KK. Hematol Oncol Stem Cell Ther; 2018 Jun 08; 11(2):82-89. PubMed ID: 29079128 [Abstract] [Full Text] [Related]
11. DNMT3A R882 Mutation with FLT3-ITD Positivity Is an Extremely Poor Prognostic Factor in Patients with Normal-Karyotype Acute Myeloid Leukemia after Allogeneic Hematopoietic Cell Transplantation. Ahn JS, Kim HJ, Kim YK, Lee SS, Jung SH, Yang DH, Lee JJ, Kim NY, Choi SH, Jung CW, Jang JH, Kim HJ, Moon JH, Sohn SK, Won JH, Kim SH, Kim DD. Biol Blood Marrow Transplant; 2016 Jan 08; 22(1):61-70. PubMed ID: 26234722 [Abstract] [Full Text] [Related]
17. The effect of haploidentical hematopoietic stem cell transplantation on comutations based on next-generation sequencing in adult acute myeloid leukemia patients with the FLT3-ITD mutation. Tang F, Zhao X, Ruan G, Jiang Q, Jiang H, Xu L, Wang Y, Zhang X, Liu K, Huang X. Hematol Oncol; 2023 Oct 08; 41(4):733-742. PubMed ID: 37272204 [Abstract] [Full Text] [Related]
18. FMS-Like Tyrosine Kinase 3 (FLT3) and Nucleophosmin 1 (NPM1) in Iranian Adult Acute Myeloid Leukemia Patients with Normal Karyotypes: Mutation Status and Clinical and Laboratory Characteristics. Rezaei N, Arandi N, Valibeigi B, Haghpanah S, Khansalar M, Ramzi M. Turk J Haematol; 2017 Dec 01; 34(4):300-306. PubMed ID: 28294102 [Abstract] [Full Text] [Related]
19. FLT3-ITD Allelic Ratio and NPM1 Mutation Do Not Impact Outcomes in Acute Myeloid Leukemia Patients with FLT3-ITD after Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Propensity Score- Matching Study. Zhou C, Zheng F, Xu L, Zhang X, Chang Y, Mo X, Sun Y, Huang X, Wang Y. Transplant Cell Ther; 2023 Jul 01; 29(7):456.e1-456.e11. PubMed ID: 37028555 [Abstract] [Full Text] [Related]